Indian pharma firm Granules opens packaging facility in US' Virginia

Indian pharmaceutical company Granules has opened a packaging facility in the Virginia State of the US to expand the packaging capacity of essential drugs in the state, thus strengthening the biopharma supply chain. The facility was inaugurated by India's Ambassador to the US Taranjit Singh Sandhu. Granules, which was one of the first Indian pharmaceutical companies that received FDA authorization to export to the United States, has invested more than USD 100 million in the country, said Dr Krishna Prasad Chigurupati, the founder, chairman and managing director of the firm. "We have nearly 200 employees in Virginia with a large majority of them first-generation Indians," he said, adding the company also has a team of 30 scientists for research and development. Granules India Ltd produces some of the most widely used drugs, including Paracetamol, that have been very useful to billions across the world, Chigurupati said. "Happy to see Made in India' medicines value added in the US b
30-03-2023
Bigul

Granules India gets USFDA nod for gabapentin tablets

US market for gabapentin tablets is valued at about $145 million a year
29-03-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Consumer Health Inc., inaugurates its Packaging Facility in the U.S.
29-03-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited Received ANDA Approval for Gabapentin Tablets
29-03-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window

Closure of Trading Window
28-03-2023

Granules India shares rise as arm concludes US FDA audit

Granules Consumer Health's packaging unit in Manassas was inspected by the US FDA from March 15-20.
21-03-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Consumer Health Inc., concludes FDA Audit with Zero Observations
21-03-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Resignation of Director

Resignation of Mr. Robert George Cunard as an Independent Director
17-03-2023
Bigul

Granules India gets USFDA nod for hypertension drug

The drug is indicated for treatment of hypertension in adults and paediatric patients 6 years of age and older
27-02-2023
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited Received ANDA Approval for Losartan Potassium Tablets
27-02-2023
Next Page
Close

Let's Open Free Demat Account